ArticleBlood advances2026

Outcomes of patients over 70 years treated with brexu-cel for R/R mantle cell lymphoma: a study from the CTIWP of EBMT.

Nicole Santoro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.